180 related articles for article (PubMed ID: 25412389)
1. Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.
Howlader N; Chen VW; Ries LA; Loch MM; Lee R; DeSantis C; Lin CC; Ruhl J; Cronin KA
Cancer; 2014 Dec; 120 Suppl 23():3771-80. PubMed ID: 25412389
[TBL] [Abstract][Full Text] [Related]
2. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic factors for melanoma of the skin using SEER registries: collaborative stage data collection system, version 1 and version 2.
Kosary CL; Altekruse SF; Ruhl J; Lee R; Dickie L
Cancer; 2014 Dec; 120 Suppl 23():3807-14. PubMed ID: 25412392
[TBL] [Abstract][Full Text] [Related]
4. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010.
Charlton ME; Adamo MP; Sun L; Deorah S
Cancer; 2014 Dec; 120 Suppl 23(0 23):3815-25. PubMed ID: 25412393
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.
Schymura MJ; Sun L; Percy-Laurry A
Cancer; 2014 Dec; 120 Suppl 23():3758-70. PubMed ID: 25412388
[TBL] [Abstract][Full Text] [Related]
7. Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
Breaux A; Turner B; Wu X; Rai SN; Riley EC; Mandadi M; Sanders MA
Clin Breast Cancer; 2019 Feb; 19(1):e261-e269. PubMed ID: 30509870
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2.
Altekruse SF; Dickie L; Wu XC; Hsieh MC; Wu M; Lee R; Delacroix S
Cancer; 2014 Dec; 120 Suppl 23(0 23):3826-35. PubMed ID: 25412394
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 database.
Wang M; Chen H; Wu K; Ding A; Zhang M; Zhang P
Breast; 2018 Feb; 37():56-63. PubMed ID: 29100045
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
[TBL] [Abstract][Full Text] [Related]
11. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SEER registries: AJCC and collaborative stage data collection system.
Chen VW; Hsieh MC; Charlton ME; Ruiz BA; Karlitz J; Altekruse SF; Ries LA; Jessup JM
Cancer; 2014 Dec; 120 Suppl 23(0 0):3793-806. PubMed ID: 25412391
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey.
Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D
J BUON; 2013; 18(3):619-22. PubMed ID: 24065473
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of the Oncotype DX Recurrence Score in T
Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H
Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the hormone receptor and HER2 levels in breast cancer: a population-based analysis.
Tas F
Onkologie; 2012; 35(3):95-8. PubMed ID: 22414972
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.
Iwase H; Kurebayashi J; Tsuda H; Ohta T; Kurosumi M; Miyamoto K; Yamamoto Y; Iwase T
Breast Cancer; 2010 Apr; 17(2):118-24. PubMed ID: 19466512
[TBL] [Abstract][Full Text] [Related]
19. Concordance between HER-2 and steroid hormone receptor expression between primary breast cancer, sentinel node metastases, and isolated tumor cells.
Strien L; Leidenius M; von Smitten K; Heikkilä P
Pathol Res Pract; 2010 Apr; 206(4):253-8. PubMed ID: 20138441
[TBL] [Abstract][Full Text] [Related]
20. Discordant expression of hormone receptors and HER2 in breast cancer. A retrospective comparison of primary tumors with paired metachronous recurrences or metastases.
Arapantoni-Dadioti P; Valavanis C; Gavressea T; Tzaida O; Trihia H; Lekka I
J BUON; 2012; 17(2):277-83. PubMed ID: 22740206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
